The Pharmacy Times® Brain Health Resource Center is a comprehensive resource for clinical news and expert insights on issues related to neural development, plasticity, functioning, and recovery associated with aging.
April 21st 2025
The breakthrough designation is supported by clinical data from ongoing phase 1/2 trials.
FDA Grants Approval to Generic Extended-Release Memantine/Donepezil and Everolimus
Published: January 23rd 2025 | Updated: January 23rd 2025Memantine/donepezil and everolimus are used to treat dementia of the Alzheimer type and tuberous sclerosis complex-associated subependymal giant cell astrocytoma, respectively.
Read More
Pharmacists Can Help Patients Navigate Current Treatment Landscape of Alzheimer Disease
January 10th 2025The pharmacist’s role includes educating and making recommendations, collaborating with health care professionals, and observing early signs of cognitive impairment in patients during interactions.
Read More
Human-Specific Genes Can Modify Expressions of Mutations That Lead to Neurodevelopmental Disorders
October 29th 2024The investigators found that the SRGAP2 and SYNGAP1 genes act together to control the speed of human synapse development, which has impacts on neurodevelopmental disease pathways.
Read More